Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 75 publications.
Herring WL, Zhang Y, Pearson I, Tempest M, Freudensprung U, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland. Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 22, 2018. Los Angeles, CA. Previously presented at the 7th Joint ECTRIMS-ACTRIMS Meeting.
Arokiasamy P, Uttamacharya , Kowal P, Capistrant BD, Gildner TE, Thiele E, Biritwum RB, Yawson AE, Mensah G, Maximova T, Wu F, Guo Y, Zheng Y, Kalula SZ, Salinas Rodríguez A, Manrique Espinoza B, Liebert MA, Eick G, Sterner KN, Barrett TM, Duedu K, Gonzales E, Ng N, Negin J, Jiang Y, Byles J, Madurai SL, Minicuci N, Snodgrass JJ, Naidoo N, Chatterji S. Chronic noncommunicable diseases in 6 low- and middle-income countries: findings from Wave 1 of the World Health Organization's Study on global AGEing and adult health (SAGE). Am J Epidemiol. 2017 Mar 15;185(6):414-28.